|
Pharmaceutical industry donations, including legislative and statewide, filed with state authorities from 2001 to 2004. (nearest $10,000) Click on the total to see how the states stack up:
| 2001 |
$3,090,000 |
| 2002 |
$6,340,000 |
| 2003 |
$3,410,000 |
| 2004 |
$5,050,000 |
| Other/Date Not Available |
$590,000 |
| Total |
$18,470,000 |
Pharmaceutical interests that donated at least half a million dollars to state races, including legislative and statewide from 2001 to 2004 (nearest $100,000):
| Pfizer Inc. |
$3,000,000 |
| GlaxoSmithKline |
$2,300,000 |
| Eli Lilly and Co. |
$2,200,000 |
| Merck & Co. |
$1,400,000 |
| Johnson & Johnson |
$1,300,000 |
Source: Institute on Money in State Politics, with analysis by Center for Public Integrity |
State-level lobbying by pharmaceutical companies in 2003 and 2004. (nearest $100,000) Click on the total to see how the states stack up:
Pharmaceutical interests that spent at least $2 million lobbying state government in 2003 and 2004 (nearest $100,000):
| Pharmaceutical Research & Manufacturers of America |
$4,500,000 |
| Eli Lilly and Co. |
$4,300,000 |
| GlaxoSmithKline |
$4,100,000 |
| Pfizer Inc. |
$4,000,000 |
| Johnson & Johnson |
$3,100,000 |
| Bristol-Myers Squibb Co. |
$2,300,000 |
| Merck & Co. |
$2,100,000 |
| Roche Holding AG |
$2,000,000 |
| Schering-Plough Corp. |
$2,000,000 |
| Novartis AG |
$1,900,000 |
Source: Center for Public Integrity analysis of state records |
